{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:39:18Z","timestamp":1780958358633,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jemermed.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T08:28:18Z","timestamp":1556008098000},"page":"e1-e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a\u00a0Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor"],"prefix":"10.1016","volume":"57","author":[{"given":"Robert","family":"Allison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandi W.","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2019.03.011_bib1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jemermed.2019.03.011_bib2","article-title":"Metabolic ketoacidosis with normal blood glucose: a rare complication of sodium-glucose cotransporter 2 inhibitors","volume":"4","author":"Ullah","year":"2016","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.jemermed.2019.03.011_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/omcr\/omw061","article-title":"The DKA that wasn\u2019t: a case of euglycemic diabetic ketoacidosis due to empagliflozin","volume":"2016","author":"Candelario","year":"2016","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.jemermed.2019.03.011_bib5","doi-asserted-by":"crossref","first-page":"e11056","DOI":"10.1097\/MD.0000000000011056","article-title":"Euglycemic diabetic ketoacidosis caused by dapagliflozin: a case report","volume":"97","author":"Chou","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jemermed.2019.03.011_bib6","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.2337\/dc16-0728","article-title":"A case of euglycemic diabetic ketoacidosis following long-term empagliflozin therapy","volume":"39","author":"Farjo","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jemermed.2019.03.011_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jemermed.2019.03.011_bib8","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2337\/dc15-1797","article-title":"Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes after treatment with empagliflozin","volume":"39","author":"Roach","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jemermed.2019.03.011_bib9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jemermed.2019.03.011_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/DMSO.S50516","article-title":"Management of adult diabetic ketoacidosis","volume":"7","author":"Gosmanov","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jemermed.2019.03.011_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12911-016-0377-1","article-title":"Cognitive biases associated with medical decisions: a systematic review","volume":"16","author":"Saposnik","year":"2016","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919301374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919301374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:29Z","timestamp":1760028209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467919301374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0736467919301374"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.03.011","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a\u00a0Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}